Related Experiment Videos

Differential inhibition of the MLR by iron: association with HLA phenotype

Immunogenetics
|January 1, 1981
PubMed

Insights

Iron exposure inhibits mixed lymphocyte reactions (MLR) in a dose-dependent manner, affecting responder cells and varying with HLA phenotype. This suggests iron influences immune function, potentially impacting disease prognosis.

Area of Science:

  • Immunology
  • Hematology
  • Medical Science

Background:

  • The mixed lymphocyte reaction (MLR) is a key measure of T-cell mediated immune response.
  • Investigating the impact of essential trace elements like iron on immune cell function is crucial for understanding health and disease.

Purpose of the Study:

  • To determine the in vitro effect of ferric-citrate on the mixed lymphocyte reaction (MLR).
  • To explore the relationship between iron's immunomodulatory effects and human leukocyte antigen (HLA) phenotype.

Main Methods:

  • Peripheral blood mononuclear cells (PBMCs) from 77 Caucasians were pretreated with varying concentrations of ferric-citrate.
  • Cells were then cultured in a one-way MLR assay.
  • Cell viability, MLR response, and influence of HLA type were assessed.

Main Results:

  • Ferric-citrate inhibited the MLR in a dose-dependent manner, primarily affecting responder cells.
  • The degree of inhibition varied with HLA phenotype, with HLA-A2 positive donors showing less susceptibility.
  • Citrate alone and cell viability were unaffected; no sex-based differences were observed.

Conclusions:

  • Iron interacts with lymphoid cells, modulating immune responses in vitro.
  • These findings suggest a potential in vivo role for iron in immune function and disease prognosis, particularly in relation to specific HLA types.

Related Concept Videos